Work

Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)‐activated thapsigargin prodrug

Year: 2005

Type: article

Source: The Prostate

DOI: 10.1002/pros.20348

Authors: Samuel Janssen, D. Marc Rosen, Rebecca M. Ricklis, Craig A. Dionne, Hans Lilja, Soeren B. Christensen, John T. Isaacs, Samuel R. Denmeade

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Targeting of the Androgen Receptor in Prostate Cancer, SPORE in Prostate Cancer, G6963922342, G877413400

OpenAlex ID: W2165594693

FWCI: 2.957

Cites: 31

Cited by: 56

Related to: 10